Patent Assignment
Reel/Frame 064263/0640
Assignment of Assignor's Interest
Recorded: 2023-07-14
Pages: 5
Assignor
JANSSEN PHARMACEUTICA NV
Executed: 2023-07-12
Assignee
JANSSEN BIOTECH, INC.
800/850 RIDGEVIEW DRIVE, HORSHAM, PENNSYLVANIA, 19044
Covered Properties
(4)
Anti- GPRC5D Antibodies, Bispecific Antigen Binding Molecules That Bind GPRC5D and CD3, and Uses Thereof
Application:
62/364,811 →
Anti- GPRC5D Antibodies, Bispecific Antigen Binding Molecules That Bind GPRC5D and CD3, and Uses Thereof
Anti- GPRC5D Antibodies, Bispecific Antigen Binding Molecules That Bind GPRC5D and CD3, and Uses Thereof
Anti- GPRC5D Antibodies, Bispecific Antigen Binding Molecules That Bind GPRC5D and CD3, and Uses Thereof
Patent:
11,884,722 →
Application:
18/157,800 →
Publication:
US 2023/0227548
PCT:
PCT/US2017/042982 ↗
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 6, 2017
From: ATTAR, RICARDO; CHIN, DIANA; EDAVETTAL, SUZANNE; GAUDET, FRANCOIS
To: JANSSEN PHARMACEUTICA NV
Reel/Frame 042700/0899 →
Assignment of Assignor's Interest
Jul 14, 2023
From: ATTAR, RICARDO; GAUDET, FRANCOIS; TORNETTA, MARK; TEPLYAKOV, ALEXEY
To: JANSSEN PHARMACEUTICA NV
Reel/Frame 064275/0373 →